PETMED EXPRESS, INC. Cash and Restricted Cash
PETMED EXPRESS, INC. (PETS) had Cash and Restricted Cash of $13.08 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $13.08M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $21.41M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $26.91M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $36.10M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $13.08M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $21.41M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $26.91M 10-Q · filed 2026-02-05 |
| 2025-09-30 | $36.10M 10-Q · filed 2025-12-19 |
| 2025-06-30 | $41.13M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $54.72M 10-Q · filed 2026-08-13 |
| 2024-12-31 | $50.10M 10-Q · filed 2026-02-05 |
| 2024-09-30 | $52.05M 10-Q · filed 2025-12-19 |
| 2024-06-30 | $45.99M 10-Q · filed 2025-12-19 |
| 2024-03-31 | $55.30M 10-K · filed 2026-06-02 |
| 2023-12-31 | $49.44M 10-Q · filed 2025-02-10 |
| 2023-09-30 | $53.47M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $61.53M 10-Q · filed 2024-08-07 |
| 2023-03-31 | $104.09M 10-K · filed 2026-06-02 |
| 2022-12-31 | $102.43M 10-Q · filed 2024-04-15 |
| 2022-09-30 | $96.55M 10-Q/A · filed 2024-04-15 |
| 2022-06-30 | $105.41M 10-Q/A · filed 2024-04-15 |
| 2022-03-31 | $111.08M 10-K · filed 2025-10-14 |
| 2021-12-31 | $108.91M 10-Q · filed 2023-02-07 |
| 2021-09-30 | $106.56M 10-Q · filed 2022-11-08 |
| 2021-03-31 | $118.72M 10-Q · filed 2023-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS HEALTH Corp (CVS) | United States | $108.783B | 27.06 |